ARS Pharmaceuticals (SPRY) to Report Q2 Earnings on August 13
SPRY ARS Pharmaceuticals Inc
$3.57 +13.33%
View chart & analysis → - 1ARS Pharmaceuticals (SPRY) will release its second-quarter results on August 13, 2026.
- 2Consensus calls for Q2 revenue of $31.32 million and EPS of -$0.49.
- 3The full-year revenue estimate has been revised down over the past 90 days, from $146.99 million to $139.71 million.
Source GuruFocus.com +1 · View original ↗
Nothing hidden: past picks and how they did against the S&P 500.